Medline's MDLN.O shares down 1.9% premarket at $42.08 as ~$3.1 bln secondary offering priced just months after medical supplier's Dec public debut
MDLN late Weds announced sale of 75 mln shares by Blackstone BX.N, Carlyle CG.O, Hellman & Friedman (H&F) and Abu Dhabi Investment Authority (ADIA) at $41
Offering price represents 4.4% discount to stock's last close of $42.88
MDLN's stock closed at $45.85 on Mon, prior to offering launch early Tues, having surged 58% since co's $7.2 bln IPO (inclusive of full overallotment), 2025's largest
Private equity backers BX, CG and H&F offloaded 23.3 mln shares each, ADIA sold 5.1 mln shares, per the offering prospectus
Northfield, Illinois-based MDLN has ~1.3 bln shares outstanding
Goldman Sachs, Morgan Stanley, BofA and JP Morgan global coordinators and joint bookrunners for offering
20 of 25 analysts rate the stock "strong buy" or "buy", rest "hold"; median PT $55, per latest LSEG data